×

Inside AbbVie's exclusive deal

1:58 PM ET Mon, 22 Dec 2014

After Express Scripts exclusively selected AbbVie over Gilead and JNJ for its hepatitis C drug, CNBC's Meg Tirrell discusses how the news has impacted the entire biotech industry.